WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 15-Jul-2015 (Data received as of 10-Jul-2015)
Next overall update Fall 2015
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 312
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 382

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 53  53  53  52  52  52  47  31 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years
Female 15-49 years 13  13  13  13  13  14  12 

Number of reported case

(Click for retrospective incidence data for Marshall Islands (the))
Diphtheria
Japanese encephalitis
Measles 14 
Mumps
Pertussis
Polio*
Rubella
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)**
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Marshall Islands (the))
Vaccine year result method % card seen                                                
BCG 2006  70  DHS   75  89  93  97  99  89  49 
DTP1 2006  71  DHS   75  97  73  97  99*  23 
DTP3 2006  48  DHS   75  78  36  80  94  39  92 
DTP4          53 
IPV1         
HepB_BD          76  70  85  99  99* 
HepB3          79  41  80  97  38 
Hib3          65  21  67  92  45 
JapEnc          13 
MCV1          79  70  78  97  94  52 
MCV2          53  42  58  90 
PCV1          70  72  83  98 
PCV3          29  22  46  24 
Pol3 2006  46  DHS   75  77  36  80  95  36  89 
Rota1          65  71  73  46 
Rota_last          44  45  60  25 
Rubella1          79  70  78  97 
TT2plus 2006  20  DHS   75  95  63  39  53 
PAB         
VAD1          13  36  17  95 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Marshall Islands (the))
BCG 89  93  97  98  99  89  49 
DTP1 97  97  97  99  99  64  97 
DTP3 78  79  80  87  94  39  92 
HepB3 79  80  80  89  97  38  10 
HepB_BD 76  81  85  92  99  99 
Hib3 65  66  67  80  92  45 
MCV1 79  79  78  88  97  94  52 
MCV2 53  56  58  74  90 
PCV3 29  38  46  35  24 
Pol3 77  79  80  88  95  36  89 
Rota_last 44  52  60  43  25 

Number of districts in the country Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
 
   
/
|
|
\
Greater or equal to 90%
From 80 to 89%
From 50 to 79%
Less than 50%
Proportion of districts
not reporting DTP3 coverage
100
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 2, 4, 6, 12 months; 4-6 years; Yes
DTaPHepIPV 2, 4, 6 months; Yes
DTaPHibIPV 2, 4, 6 months; Yes
HPV 11-12 years; Yes
HepB birth; 2, 6 months; Yes
Hib 2, 4, 12 months; Yes
IPV 2, 4, 6 months; 4-6 years; Yes
Influenza_Adult >= 50 years; Yes and adults with chronic illness, pregnant women and health care workers
Influenza_Pediatric 6 months to 4 years; Yes and children with chronic illness
MMR 12, 13 months; Yes
MenC_conj 11-12 years;
Pneumo_conj 2, 4, 6, 12 months; Yes
Rotavirus 2, 4, 6, 12 months; Yes
Td Yes every 10 years
Tdap 11-12 years; Yes
VitaminA 6-59 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes   
What years does the MYP cover? number 2008-2014  2008-2014  2008-2012  2012-2014  2008-2012  2008-2012   
Nº of districts with microplans that include activities to raise immunization coverage number    

System performance

Total Nº districts in country number    
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100%   100  100  33  100   
Nº districts with measles (MCV1) coverage >=95% number        
% of districts with MCV1 coverage >=95% From 0 to 100%   100       

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  No  Yes   

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 100  10   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR       No  Yes     

Sources

 1  "The 2015 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.